TANT_LABORATORIES_LIMITED - Accounts


Company Registration No. 4276285 (England and Wales)
TANT LABORATORIES LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2017
TANT LABORATORIES LIMITED
COMPANY INFORMATION
Directors
Mr G Donovan
Mr N Castle
Mr P Walden
Secretary
Mr G Donovan
Company number
4276285
Registered office
Unit 8
Bedwas Business Centre
Bedwas
CAERPHILLY
Mid Glamorgan
UK
CF83 8DU
Accountants
MHA Broomfield Alexander
Ty Derw
Lime Tree Court
Cardiff Gate Business Park
CARDIFF
UK
CF23 8AB
TANT LABORATORIES LIMITED
CONTENTS
Page
Directors' report
1
Balance sheet
2
Notes to the financial statements
3 - 4
TANT LABORATORIES LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2017
- 1 -

The directors present their annual report and financial statements for the year ended 31 December 2017.

Principal activities

The company was dormant throughout the period. The assets and trade were hived into Lenstec Optical Group Limited on 1 May 2016.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr G Donovan
Mr N Castle
Mr P Walden
Results and dividends

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mr G Donovan
Director
14 June 2018
TANT LABORATORIES LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2017
31 December 2017
- 2 -
2017
2016
Notes
£
£
£
£
Current assets
Debtors
2
3,045,140
3,045,140
Net current assets
3,045,140
3,045,140
Capital and reserves
Called up share capital
3
65,000
65,000
Other reserves
35,000
35,000
Profit and loss reserves
2,945,140
2,945,140
Total equity
3,045,140
3,045,140

For the financial year ended 31 December 2017 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 14 June 2018 and are signed on its behalf by:
Mr N Castle
Director
Company Registration No. 4276285
TANT LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2017
- 3 -
1
Accounting policies
Company information

Tant Laboratories Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 8, Bedwas Business Centre, Bedwas, CAERPHILLY, Mid Glamorgan, UK, CF83 8DU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared on the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

TANT LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2017
1
Accounting policies (Continued)
- 4 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.4
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Debtors
2017
2016
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
3,045,140
3,045,140

Included in trade debtors is a balance of £3,045,140 (2016: £3,045,140) due from Lenstec Optical Group Limited, the ultimate parent company.

 

3
Called up share capital
2017
2016
£
£
Ordinary share capital
Issued and fully paid
64,935 Ordinary A of £1 each
64,935
64,935
65 Ordinary B of £1 each
65
65
65,000
65,000
4
Parent company

The ultimate parent company is Lenstec Optical Group Limited, a company registered in England & Wales.

The ultimate controlling party is considered to be Mr N Castle due to his shareholding in Lenstec Optical Group Limited.

The consolidated accounts of Lenstec Optical Group Limited are publicly available and can be obtained from Companies House, Crown Way Maindy, Cardiff.

2017-12-312017-01-01trueCCH SoftwareCCH Accounts Production 2018.200Mr G DonovanMr N CastleMr P WaldenMr G Donovan42762852017-01-012017-12-314276285bus:Director12017-01-012017-12-314276285bus:Director22017-01-012017-12-314276285bus:Director32017-01-012017-12-314276285bus:CompanySecretary12017-01-012017-12-314276285bus:RegisteredOffice2017-01-012017-12-3142762852017-12-314276285core:CurrentFinancialInstruments2017-12-314276285core:CurrentFinancialInstruments2016-12-3142762852016-12-314276285core:ShareCapital2017-12-314276285core:ShareCapital2016-12-314276285core:OtherMiscellaneousReserve2017-12-314276285core:OtherMiscellaneousReserve2016-12-314276285core:RetainedEarningsAccumulatedLosses2017-12-314276285core:RetainedEarningsAccumulatedLosses2016-12-314276285core:ShareCapitalOrdinaryShares2017-12-314276285core:ShareCapitalOrdinaryShares2016-12-314276285bus:OrdinaryShareClass12017-01-012017-12-314276285bus:OrdinaryShareClass22017-01-012017-12-314276285bus:OrdinaryShareClass12017-12-314276285bus:OrdinaryShareClass22017-12-314276285bus:EntityNoLongerTradingButTradedInPast2017-01-012017-12-314276285bus:PrivateLimitedCompanyLtd2017-01-012017-12-314276285bus:FRS1022017-01-012017-12-314276285bus:AuditExempt-NoAccountantsReport2017-01-012017-12-314276285bus:FullAccounts2017-01-012017-12-31xbrli:purexbrli:sharesiso4217:GBP